| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10918614 | Radiotherapy and Oncology | 2014 | 4 Pages |
Abstract
The EURECCA panel summarized available evidence in an attempt to reduce variance in rectal cancer management. This is expected to benefit patients. Results from ongoing randomized trials will help clarify some of the issues that are still under debate.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Vincenzo Valentini, Bengt Glimelius, Karin Haustermans, Corrie A.M. Marijnen, Claus Rödel, Maria Antonietta Gambacorta, Petra G. Boelens, Cynthia Aristei, Cornelis J.H. van de Velde,